a bias toward that which favors active ECM remodeling.
Salter and co-workers (2006, this issue) have explored the possibility that the occurrence of striae may allow for prediction of pelvic relaxation in women in later life. Genitourinary prolapse is a common condition, with an estimated 11% of women requiring at least one surgical reparative procedure (Olsen et al., 1997) . Hence, identification of earlier indicators of whether an individual is at an increased risk of developing this complaint would be of major interest to patients and clinicians alike and allow for the use of noninvasive treatment modalities. Previous studies have identified multitudinous risk factors for pelvic relaxation, including aging and childbirth, although no clearly defined indicator has yet been found (Ulmsten et al., 1987) . As both striae and pelvic relaxation share -at least in part -some common ECM pathology, the investigation of the use of preexisting striae as a putative indicator for subsequent pelvic relaxation is of value.
The findings of Salter et al. (2006) suggest that, even with relatively small numbers in the study groups, striae were significantly more common in individuals with prolapse than in those without genitourinary symptoms. Interestingly, even though the examined groups did not differ widely in age, there were significant differences in their menopausal status, with the majority of the nonprolapse group being postmenopausal. This may be just a reflection of where the reference pool was drawn from (individuals of advanced age attending Mohs clinic for excision of nonmelanoma skin cancers); however, it may also reflect the importance of estrogens in ECM response to stress and/or in Striae are a common disfiguring skin condition often occurring in pregnancy but also seen in a number of clinical conditions including obesity, diabetes mellitus, and Cushing's and Marfan's syndromes; as such, they are thought to result from progressive, continuous stretching of the skin. Regardless of their etiology, they have the same clinical appearance, initially appearing as raised pink to purple (active) linear lesions, which mature over time to leave depressed pale silver "scars." Such "scarring" can have profound psychological effects (Bergfeld, 1999) . Similarly, prolapse of the pelvic organs, manifesting as urinary and/or fecal incontinence, sensations of pressure or pain, and physical protrusion, also have extreme consequences for an individual's quality of life (Uebersax et al., 1995) .
Studies of these conditions have hypothesized that changes in the extracellular matrices (ECMs) of the corresponding tissues play key roles in the pathobiology of both striae and pelvic relaxation. There are conflicting arguments as to whether changes in the collagenous or elastic components of the dermal ECM drive the patho logy observed in striae. Reductions in collagen gene expression have been observed (Lee et al., 1994) and reorganization of the collagenous matrix has been noted in numerous studies, with fibroblasts often described as "quiescent." However, more recent functional analyses of fibroblasts explanted from active lesional skin have determined that these cells possess a contractile phenotype more akin to myofibroblasts than to cells from mature lesions or cells explanted from healthy volunteers (Viennet et al., 2005) . Work from our group and others further suggests that it is the elastic fiber network that is more prone to reorganization and/or destruction in active striae, with elastolysis (Sheu et al., 1991) and alterations in both elastic fibers and the fibrillin-rich microfibrillar apparatus proximal to the dermal-epidermal junction (Watson et al., 1998) . The mechanisms underlying pelvic prolapse appear to be clearer than those resulting in striae: abnormalities in collagen metabolism have been found and corroborated in numerous studies (Phillips et al., 2006) and include reduced total collagen and altered ratios of remodeling enzymes (matrix metalloproteinases) to their naturally occurring inhibitors, the tissue inhibitors of metalloproteinases (TIMPs) (Ashcroft et al., 2003; Mills et al., 2005) . It has been postulated that striae may result from an exaggerated wound healing process (Pinkus et al., 1966) , and, clinicallyin pregnancy at least -the severity of striae appears to be related to a younger maternal age, although the age of onset of striae was not recorded by Salter et al. (2006) . Of further interest is a significantly higher occurrence of varicosities in those individuals also presenting with striae (Salter et al., 2006) . It is plausible that these phenomena describe a generalized deterioration of ECM structures that could result from a number of biological events.
The study by Salter et al. (2006) presents an appealing relationship between the occurrence of skin striae and pelvic relaxation. It will be interesting to see whether prospective studies in this area can confirm whether clinical dermatological examination can identify, and therefore target therapy to, individuals at risk of prolapse in later life.
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The author states no conflict of interest. Psoriasis is a common skin disorder, and estimates of its prevalence vary from 0.5% to 4.6% of the world population. A significant proportion of patients may also exhibit psoriatic arthritis, although the onset of arthritis can precede the development of psoriasis. Psoriasis is an inflammatory disorder that is characterized by epidermal hyperplasia, increases in keratin expression, and recruitment of T cells as well as changes in the endothelial vascular system (Bos et al., 2005; Bowcock and Krueger, 2005; Krueger and Ellis, 2005) . On the basis of the analysis of the cytokines produced, psoriasis is often considered to be a T-helper 1 condition, as levels of IFN-γ, tumor necrosis factor (TNF), IL-1, IL-2, IL-6, and IL-8 are increased in psoriatic lesions. The recruitment of T cells is likely to be critical to the development of the disease; however, the immunology of psoriasis is complex, and several other cell types, including dendritic cells, phagocytes, and keratinocytes, are also likely to play a role (Bos et al., 2005; Bowcock and Krueger, 2005; Krueger and Ellis, 2005) . Recent advances in treatment have confirmed a role for T cells in psoriasis, and agents that target T cells, such as alefacept and efalizumab, have been shown to reduce the symptoms of psoriasis. Interestingly, anti-TNF therapies have also proved effective at treating psoriasis, demonstrating a critical role for this cytokine in the condition (Bos et al., 2005; Bowcock and Krueger, 2005;  
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